Call Us + 33 1 84 88 31 00

Article R6123-93-1 of the French Public Health Code

When the applicant for an authorisation including the mention of external radiotherapy and brachytherapy provided for in 2° of article R. 6123-86-1 is not a health establishment, this authorisation may only be issued or renewed if the facilities it uses to carry out its activity are located within the enclosure or in neighbouring buildings of a health establishment holding the authorisation provided for in article R. 6123-86. The authorisation is…

Read More »

Article R6123-93-2 of the French Public Health Code

I.- Authorisation to carry out the activity of cancer treatment by external radiotherapy may only be granted or renewed to an applicant who has a technical platform comprising at least two particle accelerators on the same site. II.- Authorisation may exceptionally be granted to an applicant who has only one particle accelerator.However, by way of exception, authorisation may be granted to an applicant who has only one particle accelerator, where…

Read More »

Article R6123-93-3 of the French Public Health Code

The holder of the radiotherapy authorisation has the following facilities on the site: 1° A radiotherapy unit with radiotherapy equipment used for the external radiotherapy or brachytherapy treatment of patients, and where appropriate the preparation of these treatments. The unit also contains consultation rooms; 2° A technical imaging platform enabling radiotherapy treatment to be prepared and monitored by the dedicated care team. This imaging centre has at least one dedicated…

Read More »

Article R6123-93-4 of the French Public Health Code

I.-When the holder of an external radiotherapy authorisation carries out treatments under stereotactic conditions, it must have at least two particle machines, at least one of which must be capable of carrying out radiotherapy treatments under stereotactic conditions. II – If the holder performs intracranial radiotherapy under stereotactic conditions for primary brain tumours, a protocol is drawn up in advance with doctors specialising in neurosurgery who perform intracranial radiosurgery under…

Read More »

Article R6123-93-5 of the French Public Health Code

I.-When the holder of an external radiotherapy authorisation carries out treatments using the proton therapy technique, he also has an authorisation on the same site to hold heavy cyclotron equipment for medical use as mentioned in 5° of article R. 6122-26. The provisions of the first two paragraphs of article R. 6123-93-2 do not apply to it. II -When the holder of the external radiotherapy licence carries out treatments using…

Read More »

Article R6123-93-6 of the French Public Health Code

I. Notwithstanding Article R. 6123-93, when a radiotherapy licensee refers a patient to a licensee who performs proton therapy, the licensee may contribute, jointly with the licensee who performs proton therapy, to the preparation of the proton therapy treatment and to the coordination of the patient’s post-treatment proton therapy follow-up under the terms of an agreement. This shared management is recorded in the patient’s medical records. It is included in…

Read More »

Article R6123-93-7 of the French Public Health Code

Notwithstanding the provisions of article R. 6123-88-1, palliative treatments for children and adolescents under the age of eighteen may be provided in external radiotherapy centres with an A or B rating, on the advice of the inter-regional paediatric multidisciplinary consultation meeting.

Read More »

Article R6123-94 of the French Public Health Code

I-Treatment of cancer by systemic medicinal treatments for cancer consists, within the authorised site : 1° The development of a therapeutic proposal in a multidisciplinary consultation meeting, following the initial diagnosis but also on the occasion of reassessment assessments; 2° The therapeutic decision on systemic cancer drug treatment, regardless of the method of administration, taken during a one-to-one interview by a prescribing doctor, as well as any decision, taken under…

Read More »

Article R6123-94-1 of the French Public Health Code

When providing systemic cancer treatment by immunotherapy or innovative therapeutic medicinal products, the holder of the authorisation for systemic cancer treatment has a patient care organisation which must guarantee a multidisciplinary territorial approach to continuity of care. This organisation includes, either on its own or in conjunction with other health establishments, direct access to a network of specialised doctors and to specialised medical technical platforms capable of dealing with foreseeable…

Read More »

Article R6123-94-1-1 of the French Public Health Code

The establishment authorised to provide systemic medicinal treatments for cancer with a C rating complies with the obligations imposed on holders of authorisations for medicine caring for children and adolescents mentioned in articles R. 6123-151 and R. 6123-158.

Read More »

Contact a French lawyer now

Contact a French Business Lawyer

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.

Useful links

You have a question in French Business Law?

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.

All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.